Brief: Adherium Receives U.S. FDA Clearance For GSK PMDI Inhaler Users To Remotely Monitor Physiological Parameters
Nov 28 (Reuters) - Adherium Ltd ADR.AX :
* RECEIVED U.S. FDA CLEARANCE FOR GSK PMDI INHALER USERS TO
REMOTELY MONITOR PHYSIOLOGICAL PARAMETERS
Source text for Eikon: ID:nASX1DyfGG
Further company coverage: ADR.AX
(Reporting by Poonam Behura)
((Poonam.Behura@thomsonreuters.com;))